Real-world Frequency of BRAF Testing and Utilization of Therapies in Patients with Advanced Melanoma

被引:0
|
作者
Hill, M. V. [1 ]
Deng, M. [1 ]
Handorf, E. [1 ]
Olszanski, A. J. [1 ]
Farma, J. M. [1 ]
机构
[1] Fox Chase Canc Ctr, Gen Surg, Bala Cynwyd, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P174
引用
收藏
页码:S108 / S108
页数:1
相关论文
共 50 条
  • [31] Real-world treatment patterns and clinical outcomes in advanced cutaneous melanoma patients in France
    Sassolas, B.
    Leccia, M. T.
    Godard, C.
    Benmahamed, L.
    Flinois, A.
    Levy-Bachelot, L.
    Bedane, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) : 587 - 594
  • [32] Real-world outcomes of advanced melanoma patients not represented in phase Ill trials.
    Ismail, Rawa
    van Zeijl, Michiel
    De Wreede, Liesbeth
    van den Eertwegh, Alfonsus Johannes Maria
    De Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Boers-Sonderen, Marye
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Suijkerbuijk, Karijn
    ten Tije, Albert J.
    Van der Veldt, Astrid Aplonia Maria
    Haanen, John B. A. G.
    Wouters, Michel W. J. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Real-world experience with pembrolizumab in patients with advanced melanoma A large retrospective observational study
    Liu, Frank Xiaoqing
    Ou, Wanmei
    Diede, Scott J.
    Whitman, Eric D.
    [J]. MEDICINE, 2019, 98 (30) : e16542
  • [34] Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
    Yu, Su-Yeon
    Mckavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Atkinson, Victoria
    Hollingworth, Samantha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1371 - 1379
  • [35] Real-world Outcomes of Patients New to Osteoporosis Therapies
    Williams, Setareh
    Weiss, Rich
    Wang, Yamei
    Cui, Lianzhou
    Nichols, Hily
    Gernert, Andrew
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1475 - 1475
  • [36] Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).
    Kirkwood, John M.
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Khushalani, Nikhil I.
    Jang, Sekwon
    Hallmeyer, Sigrun
    McDermott, David F.
    Tawbi, Hussein Abdul-Hassan
    Wan, Yin
    Wang, Rosa
    Ritchings, Corey
    Rao, Sumati
    Ramsey, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
    Kirkwood, John M.
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Khushalani, Nikhil, I
    Jang, Sekwon
    Hallmeyer, Sigrun
    McDermott, David F.
    Tawbi, Hussein
    Che, Min
    Lee, Cho-Han
    Ritchings, Corey
    Le, Trong Kim
    Park, Boas
    Ramsey, Scott
    [J]. IMMUNOTHERAPY, 2024, 16 (01) : 29 - 42
  • [38] Real-World Use of Systemic Therapies for the Treatment of Advanced Thyroid Cancers
    Chen, Debbie W.
    Banerjee, Mousumi
    Xu, Tianyi
    Worden, Francis P.
    Haymart, Megan R.
    [J]. ENDOCRINE PRACTICE, 2023, 29 (11) : 868 - 874
  • [39] Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients—real-world data
    Marta Polkowska
    Paweł Ekk-Cierniakowski
    Edyta Czepielewska
    Małgorzata Kozłowska-Wojciechowska
    [J]. European Journal of Clinical Pharmacology, 2019, 75 : 329 - 334
  • [40] The real-world cost of systemic therapies for advanced head and neck cancers
    Verma, Mrinalini
    Chakrabarti, Deep
    Rajan, Shiv
    Akhtar, Naseem
    [J]. INDIAN JOURNAL OF CANCER, 2023, 60 (03) : 411 - 414